A Rhesus THC Abstinence Study Compared Behavior With the Original Baseline
A 1980 rhesus-monkey study reported behavioral increases after repeated THC stopped, measured against behavior before THC exposure. That baseline comparison was important because becoming more active than during drug administration alone would not establish an abstinence syndrome.
The exposure conditions were intensive and specific
Restrained, catheterized monkeys received intravenous THC every six hours for three weeks. The initial injection produced heavy eyelids, immobility and low responsiveness to observation. Tolerance developed to those behaviors, though the animals remained more subdued than baseline during treatment.
Cessation produced above-baseline behaviors
After THC discontinuation, gross movement, eye contact and tooth baring increased beyond their pre-exposure frequency or duration. The authors interpreted the pattern as a probable cannabis abstinence syndrome. The observation is narrower than a direct report of subjective distress or a comprehensive withdrawal rating in humans.
Setting limits translation
Restraint, repeated intravenous administration and a prolonged scheduled regimen differ substantially from ordinary human cannabis use. The abstract does not establish a population risk estimate, severity scale or duration applicable to patients. Those specifics should not be inferred from the primate observation.
The useful methodological lesson is to compare cessation with the original baseline as well as with the drug-exposed state. This historical experiment supports a behavioral adaptation finding under its conditions, while leaving the clinical experience and prevalence of cannabis withdrawal to other evidence.
Related: interpreting cannabis tolerance claims.
Research cited
Fredericks AB; Benowitz NL. An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeys. Psychopharmacology (1980). doi:10.1007/BF00434412. Findings discussed from the study abstract.
